• English
    • Română(Romanian)
  • Company
    • Presentation
    • Recognition and awards
    • CEO’s Message
    • Mission and values
    • Quality
      • Quality Policy
      • Certifications
      • Integrated Management System
      • Contract manufacturing
    • History
  • Investors
    • Information for shareholders
      • Events Calendar
      • Shareholder Structure
      • Stock Quotes
      • Dividends handout
      • Meeting with investors
      • Presentations
      • Events
      • Analist coverage
    • The General Meeting of Shareholders
      • Procedures of the General Meeting of Shareholders
      • Archive of The General Meeting of Shareholders
    • Management’s transactions
    • Affiliated persons’ transactions
    • Financial information
      • Financial reporting
      • Annual reports
    • News release and current reports
    • Contact for Investor Relations
  • Corporate Governance
    • Reference documents
    • Governance structure
    • Transparency. Reporting obligations
    • Governance documents
    • Reports
    • Social responsability
    • National anti-corruption strategy
    • Whistleblowers in the Public Interest
    • Administrator selection procedure 2024
    • General Manager Selection Procedure 2025
  • Development
    • Research
    • Regulatory Affairs
    • Biotechnologies
    • Centre for Drug Evaluation
      • Services
      • Studies
      • Clinical trials
      • Selecting volunteers
  • Products
    • Medicines for human use
      • Over the counter drugs
      • Nutriensa
      • Cosmetic products
      • Medicines with prescription
      • Medical devices
    • Veterinary products
      • Prescription veterinary products
      • Veterinary products > VetAria+ range
    • VetAria+
    • Active pharmaceutical ingredients
    • Pharmacovigilance
  • Partners
    • Local Partners
    • Foreign partners
    • Nystatin
    • Finished products
    • Antibiotice in the world
  • Media
    • News
    • Media Relation Contact
    • Press Releases
    • Public Interest Announcements
      • Processing personal data
    • European and National Funding Projects
      • Development and innovation in health
      • Education and practical training
      • Sustainability and energy efficiency
  • Careers
    • a+ Academy
    • Open Positions
    • Benefits and development
  • Sustainability
    • ESG Reports
    • ESG Policies
      • Environmental
      • Social
      • Governance
    • Responsible for future generations
    • “Science and Soul” Foundation
    • ESG Assessments and Ratings
      • 2026 Results
      • 2025 Results
      • 2024 Results
      • 2023 Results
    • Affiliations
  • Online orders
  • Contact
    • Company Info
      • Social responsability real
    • How to contact us
    • Complains
    • Side effects from Saudi Arabia
Home > Media > News > News archive

Yearly Archives: 2019

Serbian Health professionals visiting Antibiotice Iasi

Antibiotice company awarded by ANEIR for Nistatin product

10 % increase in the gross profit in the first 9 months of 2019

We planted O2 in our community

CPHI Worldwide 2019 – New business opportunities for Antibiotice

Antibiotice SA publishes the second non-financial report “Responsible for a better life”

Vietnam’s ambassador, visiting the company that provides a quarter of the exports to this country

Sales revenue and profit earned by Antibiotice in the first semester of 2019 recorded higher values compared to those in the same period of 2018

Antibiotice associates with ARIR

“Summer School a+”, an incubator for the Antibiotice future specialists

Our current pharmacists face to face with the aspiring pharmacists!

Visit of an Israel delegation to Antibiotice

Employee children, celebrated with colorful balloons and invitation to … childhood!

Bucharest Stock Exchange in visit to Antibiotice

“Antibiotice Science and Soul” Foundation brought light to 23 needy families

Audited economic and financial results of 2018 – 8% increase in sales revenue and 2% profit after tax

Antibiotice at the Romanian-Vietnam Business Forum

Antibiotice received two awards at the Romanian CSR Awards Gala

Delegation of the French Chamber of Commerce visiting Antibiotice

Revenue from sales up 8% and net profit up 2%

2019 Stock Exchange Inauguration Gala


Copyright 2026 Antibiotice SA
Toate drepturile rezervate.
  • Company
  • Investors
  • Corporate Governance
  • Development
  • Products
  • Partners
  • Media
  • Careers
  • Sustainability
  • Contact
  • Terms and conditions of use
  • Cookie Policy
  • Processing personal data

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

  • English
  • Română (Romanian)
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Analytics

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Cookie Policy

More information about our Cookie Policy